Search

everythinglearnresearchcommunity

for

Search:↓

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Many Instagram posts about breast cancer symptoms are misleading and not created by healthcare professionals.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Endoscopic-assisted surgery leads to higher patient satisfaction in breast reconstruction.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Lactating women need education on maintaining adequate zinc levels.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Docetaxel treatment for breast cancer can cause permanent hair loss.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.